Publication | Open Access
Erk5 is a mediator to TGFβ1-induced loss of phenotype and function in human podocytes
14
Citations
34
References
2014
Year
These results describe for the first time the expression of Erk5 in podocytes and identify it as a potential target for the treatment of diabetic renal disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1